Hisamitsu Pharmaceutical Co Inc
TSE:4530
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Price:
3 750 JPY
-1.55%
Market Closed
Updated:
May 22, 2024
Hisamitsu Pharmaceutical Co Inc
Interest Income Expense
|
Hisamitsu Pharmaceutical Co Inc
Interest Income Expense Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
Interest Income Expense
¥6.4B
|
CAGR 3-Years
76%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-4%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥161.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥25.6B
|
CAGR 3-Years
136%
|
CAGR 5-Years
47%
|
CAGR 10-Years
96%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥30.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥3.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
-¥3.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
See Also
What is Hisamitsu Pharmaceutical Co Inc's Interest Income Expense?
Interest Income Expense
6.4B
JPY
6.4B
JPY
Based on the financial report for Feb 29, 2024, Hisamitsu Pharmaceutical Co Inc's Interest Income Expense amounts to 6.4B JPY.
What is Hisamitsu Pharmaceutical Co Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-4%
-4%
Over the last year, the Interest Income Expense growth was 53%. The average annual Interest Income Expense growth rates for Hisamitsu Pharmaceutical Co Inc have been 76% over the past three years , 14% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
